𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model

✍ Scribed by Xin Yang; Birgit Mertens; Enni Lehtonen; Linda Vercammen; Olivier Bockstael; Abdelwahed Chtarto; Marc Levivier; Jacques Brotchi; Yvette Michotte; Veerle Baekelandt; Sophie Sarre; Liliane Tenenbaum


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
593 KB
Volume
11
Category
Article
ISSN
1099-498X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Efficient protection of dopaminergic neurons against a subsequent 6‐hydroxydopamine lesion by glial cell line‐derived neurotrophic factor (GDNF) gene delivery has been demonstrated. By contrast, the neurorestorative effects of GDNF administered several weeks after the toxin have been less characterized. In particular, whether these were permanent or dependent on the continuous presence of GDNF remains elusive.

Methods

A tetracycline‐inducible adeno‐associated virus (AAV)‐1 vector expressing human GDNF cDNA was administered unilaterally in the rat striatum 5 weeks after 6‐hydroxydopamine. Rats were treated with doxycycline (dox) or untreated from the day of vector injection until sacrifice (4 or 14 weeks). A sub‐group was dox‐treated for 7 weeks then untreated until 14 weeks. The motor behavior was assessed by amphetamine‐induced rotations and spontaneous forelimb asymmetry. The amounts of tyrosine hydroxylase (TH), serine‐40‐phosphorylated TH (S40‐TH) and aromatic amino acid decarboxylase (AADC) proteins were compared by western blotting and the dopamine levels quantified by high‐performance liquid chromatography.

Results

Dox‐dependent behavioral improvements were demonstrated 4 weeks post‐vector injection. At later time points, spontaneous partial recovery was observed in all rats, but no further improvement was found in dox‐treated animals. TH levels were significantly increased in dox‐treated rats at all time points. By contrast, striatal dopamine and S40‐TH were increased at 4 weeks, but not 14 weeks, and AADC remained unchanged. Dox withdrawal after 7 weeks, resulted in TH levels comparable to the controls at 14 weeks.

Conclusions

Delayed GDNF gene delivery only transiently improved dopaminergic function. Over the long term, TH was more abundant, but not functional, and the increase was lost when GDNF gene expression was switched off. Copyright © 2009 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Glial cell line-derived neurotrophic fac
✍ Aleksandra Glavaski-Joksimovic; Tamas Virag; Thomas A. Mangatu; Michael McGrogan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 1 views

## Abstract Parkinson's disease (PD) is a neurodegenerative disease characterized by progressive degeneration of nigrostriatal dopaminergic (DA) neurons. The therapeutic potential of glial cell line‐derived neurotrophic factor (GDNF), the most potent neurotrophic factor for DA neurons, has been dem

Activation of the extracellular signal-r
✍ Niklas Lindgren; Rehana K. Leak; Kirsten M. Carlson; Amanda D. Smith; Michael J. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

## Abstract Glial cell line‐derived neurotrophic factor (GDNF) has been shown to be neuroprotective in animal models of the dopamine deficiency in Parkinson's disease. To examine the role of the extracellular signal‐regulated kinases 1 and 2 (ERK1/2) in this process, we infused a single dose of GDN